vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and Beneficient (BENF). Click either name above to swap in a different company.

ADC Therapeutics SA is the larger business by last-quarter revenue ($23.1M vs $18.7M, roughly 1.2× Beneficient). On growth, Beneficient posted the faster year-over-year revenue change (322.5% vs 36.4%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

Beneficient is a financial services firm specializing in alternative asset liquidity solutions. It offers tailored options for holders of illiquid alternative investments including private equity, hedge fund stakes, and real assets, serving institutional investors, high-net-worth individuals, and family offices primarily in North America.

ADCT vs BENF — Head-to-Head

Bigger by revenue
ADCT
ADCT
1.2× larger
ADCT
$23.1M
$18.7M
BENF
Growing faster (revenue YoY)
BENF
BENF
+286.1% gap
BENF
322.5%
36.4%
ADCT

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
ADCT
ADCT
BENF
BENF
Revenue
$23.1M
$18.7M
Net Profit
$19.9M
Gross Margin
Operating Margin
-77.7%
21.1%
Net Margin
106.7%
Revenue YoY
36.4%
322.5%
Net Profit YoY
330.5%
EPS (diluted)
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
BENF
BENF
Q4 25
$23.1M
$18.7M
Q3 25
$15.8M
$-2.8M
Q2 25
$18.1M
$-12.6M
Q1 25
$17.4M
$-31.0M
Q4 24
$16.9M
$4.4M
Q3 24
$18.0M
$8.6M
Q2 24
$17.0M
$10.0M
Q1 24
$17.8M
Net Profit
ADCT
ADCT
BENF
BENF
Q4 25
$19.9M
Q3 25
$-41.0M
$-17.9M
Q2 25
$-56.6M
$-92.6M
Q1 25
$-38.6M
$-44.6M
Q4 24
$-8.6M
Q3 24
$-44.0M
$9.7M
Q2 24
$-36.5M
$44.3M
Q1 24
$-46.6M
Operating Margin
ADCT
ADCT
BENF
BENF
Q4 25
-77.7%
21.1%
Q3 25
-196.6%
646.5%
Q2 25
-244.1%
734.0%
Q1 25
-163.5%
146.3%
Q4 24
-191.8%
-215.3%
Q3 24
-197.4%
-160.2%
Q2 24
-170.5%
Q1 24
-188.3%
Net Margin
ADCT
ADCT
BENF
BENF
Q4 25
106.7%
Q3 25
-260.1%
648.1%
Q2 25
-313.2%
734.0%
Q1 25
-221.8%
144.1%
Q4 24
-195.5%
Q3 24
-244.1%
113.9%
Q2 24
-214.6%
441.1%
Q1 24
-261.1%
EPS (diluted)
ADCT
ADCT
BENF
BENF
Q4 25
$0.04
Q3 25
$-0.30
Q2 25
$-0.50
Q1 25
$-0.36
Q4 24
$-0.26
Q3 24
$-0.42
Q2 24
$-0.38
Q1 24
$-0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
BENF
BENF
Cash + ST InvestmentsLiquidity on hand
$261.3M
$7.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$-185.8M
$-128.6M
Total Assets
$323.1M
$337.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
BENF
BENF
Q4 25
$261.3M
$7.9M
Q3 25
$234.7M
$4.9M
Q2 25
$264.6M
$7.6M
Q1 25
$194.7M
$1.3M
Q4 24
$250.9M
$4.1M
Q3 24
$274.3M
$4.5M
Q2 24
$300.1M
$4.4M
Q1 24
$234.3M
Stockholders' Equity
ADCT
ADCT
BENF
BENF
Q4 25
$-185.8M
$-128.6M
Q3 25
$-238.2M
$-142.8M
Q2 25
$-199.2M
$-120.4M
Q1 25
$-238.2M
$-34.9M
Q4 24
$-202.6M
$14.3M
Q3 24
$-171.9M
$-13.2M
Q2 24
$-131.7M
$-148.3M
Q1 24
$-194.4M
Total Assets
ADCT
ADCT
BENF
BENF
Q4 25
$323.1M
$337.9M
Q3 25
$289.8M
$316.2M
Q2 25
$321.6M
$334.5M
Q1 25
$272.5M
$354.9M
Q4 24
$322.0M
$400.0M
Q3 24
$349.1M
$368.8M
Q2 24
$371.8M
$361.3M
Q1 24
$308.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
BENF
BENF
Operating Cash FlowLast quarter
$-31.1M
$-9.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
0.0%
Cash ConversionOCF / Net Profit
-0.47×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
BENF
BENF
Q4 25
$-31.1M
$-9.4M
Q3 25
$-29.6M
$-14.5M
Q2 25
$-24.1M
$-10.8M
Q1 25
$-56.3M
$-37.7M
Q4 24
$-21.9M
$-10.0M
Q3 24
$-25.0M
$-8.6M
Q2 24
$-32.8M
$-10.6M
Q1 24
$-44.1M
Free Cash Flow
ADCT
ADCT
BENF
BENF
Q4 25
Q3 25
Q2 25
$-10.9M
Q1 25
$-56.6M
$-38.8M
Q4 24
$-21.9M
$-10.0M
Q3 24
$-25.3M
$-8.9M
Q2 24
$-32.9M
$-11.3M
Q1 24
$-44.6M
FCF Margin
ADCT
ADCT
BENF
BENF
Q4 25
Q3 25
Q2 25
86.6%
Q1 25
-325.2%
125.3%
Q4 24
-129.8%
-227.2%
Q3 24
-140.2%
-103.7%
Q2 24
-193.0%
-112.6%
Q1 24
-250.0%
Capex Intensity
ADCT
ADCT
BENF
BENF
Q4 25
0.0%
0.0%
Q3 25
0.0%
0.0%
Q2 25
0.0%
-0.8%
Q1 25
1.5%
-3.5%
Q4 24
0.5%
1.0%
Q3 24
1.2%
3.1%
Q2 24
0.2%
6.6%
Q1 24
3.0%
Cash Conversion
ADCT
ADCT
BENF
BENF
Q4 25
-0.47×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-0.88×
Q2 24
-0.24×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADCT
ADCT

Segment breakdown not available.

BENF
BENF

Ben Liquidity$8.2M44%
Other$7.6M41%
Ben Custody$2.9M16%

Related Comparisons